When standard ophthalmology has exhausted its toolkit—when steroid drops lose their effectiveness, or when laser intervention isn’t an option for a particular retinal pathology—patients often find themselves in a clinical limbo. For conditions like chronic dry eye syndrome, glaucoma with progressive field loss despite normalized intraocular pressure, or macular edema that resists anti-VEGF injections, the question shifts from “what can we do?” to “is there anything left?” Acupuncture, as a complementary medical approach, has been studied for its effects on ocular blood flow and neuroprotection. One practical point: research suggests that needling specific periocular and distal points (e.g., ST36 and GB20) may increase choroidal perfusion, which is relevant for ischemic optic neuropathies where conventional therapy has plateaued. A second genuinely useful consideration is the frequency of treatment—unlike a pharmaceutical regimen, acupuncture typically requires 8–12 sessions over 6–8 weeks before vascular or inflammatory markers show measurable change; asking for a mid-course reassessment with your primary eye doctor is wise, not optional. Third, for patients with autoimmune uveitis who are steroid-dependent, acupuncture may help modulate systemic inflammation, but it should never replace immunosuppressants—it is an adjunct, not a substitute. If you are weighing this option for a condition your specialist has called “untreatable,” you might find this helpful overview that outlines realistic outcomes and safety parameters in a medical context. Ultimately, the goal is not to abandon your ophthalmologist but to expand the team, ensuring that any alternative therapy is documented and monitored alongside your existing care plan.
For more on this topic, visit this helpful overview.
No comments:
Post a Comment